Zika vaccine candidate shows promise in early human trial
⭐️ VACCINE ⭐️
Completed
This study tested a new vaccine called VLA1601 to see if it is safe and can protect against the Zika virus, which can cause serious birth defects. The trial involved 150 healthy adults aged 18 to 49 who had never been exposed to similar viruses. Participants received two shots of…
Phase: PHASE1 • Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:06 UTC